Citadel Advisors’s Innophos Holdings, Inc. IPHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-6,200
| Closed | -$275K | – | 10120 |
|
|
2018
Q3 | $275K | Buy |
6,200
+700
| +13% | +$32K | ﹤0.01% | 7718 |
|
|
2018
Q2 | $262K | Buy |
+5,500
| New | +$250K | ﹤0.01% | 7446 |
|
|
2017
Q1 | – | Sell |
-5,600
| Closed | -$293K | – | 8312 |
|
|
2016
Q4 | $293K | Buy |
+5,600
| New | +$272K | ﹤0.01% | 5704 |
|
|
2016
Q3 | – | Sell |
-5,200
| Closed | -$219K | – | 8032 |
|
|
2016
Q2 | $219K | Buy |
+5,200
| New | +$195K | ﹤0.01% | 5701 |
|
|
2016
Q1 | – | Sell |
-200
| Closed | -$6K | – | 8542 |
|
|
2015
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 8423 |
|
|
2015
Q3 | $8K | Sell |
200
-800
| -80% | -$38.7K | ﹤0.01% | 8548 |
|
|
2015
Q2 | $53K | Buy |
1,000
+600
| +150% | +$32.6K | ﹤0.01% | 7621 |
|
|
2015
Q1 | $23K | Sell |
400
-700
| -64% | -$40.9K | ﹤0.01% | 7833 |
|
|
2014
Q4 | $64K | Sell |
1,100
-2,300
| -68% | -$129K | ﹤0.01% | 7018 |
|
|
2014
Q3 | $187K | Sell |
3,400
-1,400
| -29% | -$81.2K | ﹤0.01% | 5792 |
|
|
2014
Q2 | $276K | Sell |
4,800
-3,500
| -42% | -$191K | ﹤0.01% | 5167 |
|
|
2014
Q1 | $471K | Buy |
8,300
+3,900
| +89% | +$200K | ﹤0.01% | 4420 |
|
|
2013
Q4 | $214K | Buy |
4,400
+1,800
| +69% | +$89.8K | ﹤0.01% | 4961 |
|
|
2013
Q3 | $137K | Sell |
2,600
-2,200
| -46% | -$111K | ﹤0.01% | 5104 |
|
|
2013
Q2 | $226K | Buy |
+4,800
| New | +$248K | ﹤0.01% | 4562 |
|
Other funds holding IPHS
Citadel Advisors's IPHS Position: Q1 2020 in Review
Citadel Advisors sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 18,893 shares — an estimated $604K sold.
Citadel Advisors first reported a position in IPHS in Q2 2013 and held it in 27 quarters. The position peaked at $4.72M in Q1 2014. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.
- Citadel Advisors reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 18,893 Innophos Holdings, Inc. shares in Q1 2020, an estimated $604K.
- Citadel Advisors first reported a position in Innophos Holdings, Inc. in Q2 2013 and held it in 27 quarters.
- Citadel Advisors's Innophos Holdings, Inc. position peaked at $4.72M in Q1 2014.
- 2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.